
Understanding 46,XX Ovarian Dysgenesis-Short Stature Syndrome: A Genetic Insight
Primary amenorrhea, short stature and hormonal imbalance appear despite a normal 46,XX karyotype; hormone replacement follows once testing points to the cause.

MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.

Primary amenorrhea, short stature and hormonal imbalance appear despite a normal 46,XX karyotype; hormone replacement follows once testing points to the cause.

Testes that never develop leave a female phenotype in a person with an XY karyotype; finding the SRY missense mutation supports early diagnosis and counseling.

Adrenal nodules that make cortisol without ACTH signaling drive Cushing's syndrome in AIMAH2; the page covers PDE11A variants and what genetic testing can add.

Beyond scalp and limb anomalies, AOS5 can involve the cardiovascular system; identifying the ARHGAP31 variant separates it from other Adams-Oliver subtypes.

Clinical exam and family history can be inconclusive, so identifying the RELT frameshift mutation gives type 1H a definite diagnosis and shapes dental treatment.

Mutations in genes such as ALS2 underlie this form of ALS. Testing can identify at-risk people before symptoms appear and steer targeted drug development.

Risk stratification based on the mutation found sets how closely the aorta is imaged in TAAD9 and can inform the timing and approach of surgical repair.

Cerebellar ataxia, intellectual disability, oculomotor apraxia and cerebellar cysts appear together in AIDOA-CCS, where DNA analysis confirms a delayed diagnosis.